Suppr超能文献

在连续性静脉-静脉血液透析及使用高效膜的血液透析滤过过程中阿昔洛韦的清除情况。

Removal of acyclovir during continuous veno-venous hemodialysis and hemodiafiltration with high-efficiency membranes.

作者信息

Khajehdehi P, Jamal J A, Bastani B

机构信息

Department of Internal Medicine, Saint Louis University School of Medicine, MO, USA.

出版信息

Clin Nephrol. 2000 Oct;54(4):351-5.

Abstract

We present a critically ill patient with severe renal failure and anuria who underwent hemodialysis (HD), continuous veno-venous hemodialysis (CVVHD) and continuous veno-venous hemodiafiltration (CVVHDF) at different occasions, with 2 commonly used high-efficiency dialyzers (F-8 and CA-210), while receiving i.v. acyclovir. We estimate that during 24 hours of CVVHD with F-8 dialyzer approximately 18% and during 24 hours of CVVHDF with CA-210 dialyzer approximately 65% of the daily administered acyclovir is removed. This is comparable to the amount removed during 4 6 hours of HD, as reported previously. The percentage acyclovir extraction was 84% and 60% during CVVHD and CVVHDF with F-8 and CA-210 dialyzers, respectively. Acyclovir clearance during CVVHD was 14 ml/min and during CVVHDF was 17 ml/min, with F-8 and CA-210 dialyzers, respectively. Acyclovir half-life was 22.5 and 25.5 hours in 2 occasions off any type of renal replacement therapy, and it was 19.5 hours during CVVHDF with CA-210 dialyzer.

摘要

我们报告了一名患有严重肾衰竭和无尿的重症患者,该患者在不同时间接受了血液透析(HD)、连续性静脉-静脉血液透析(CVVHD)和连续性静脉-静脉血液滤过透析(CVVHDF),使用了2种常用的高效透析器(F-8和CA-210),同时接受静脉注射阿昔洛韦治疗。我们估计,在使用F-8透析器进行24小时CVVHD期间,每日给予的阿昔洛韦约有18%被清除;在使用CA-210透析器进行24小时CVVHDF期间,约有65%被清除。这与先前报道的在4至6小时HD期间清除的量相当。在使用F-8和CA-210透析器进行CVVHD和CVVHDF期间,阿昔洛韦的提取率分别为84%和60%。使用F-8和CA-210透析器时,CVVHD期间阿昔洛韦的清除率分别为14 ml/min和CVVHDF期间为17 ml/min。在未进行任何类型肾脏替代治疗的2个不同时段,阿昔洛韦的半衰期分别为22.5小时和25.5小时,而在使用CA-210透析器进行CVVHDF期间,半衰期为19.5小时。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验